Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
- de Joode, K.
- Dumoulin, D.W.
- Tol, J.
- Westgeest, H.M. (Hans)
- Beerepoot, L.V. (Laurens)
- van den Berkmortel, F.W.P.
- Mutsaers, P.G.N.J. (Pim)
- van Diemen, N.G.J.
- Visser, O.J.
- Oomen-de Hoop, E.
- Bloemendal, H.J. (Haiko)
- van Laarhoven, HW
- Hendriks, L.E.L.
- Haanen, J.B. (John)
- de Vries, E.G.
- Dingemans, A.M.A.
- van der Veldt, A.A.M.
- Loenhout, C.J. (Keetie) van
- van der Leest, C.H.
- Becker-Commissaris, A.
- Borgers, J.S.W.
- Terhegggen, F.
- van den Borne, BE
- van Warmerdam, L.J.C.
- van Leeuwen, L.
- van der Meer, F.S.
- Tiemessen, M.A.
- van Diepen, D.M.
- Klaver, Y.
- Hamberg, A.P. (Paul)
- Libourel, E.J. (Eduard)
- Strobbe, L.
- Cloos, M.
- Geraedts, E.J.
- Drooger, J.C. (Jan)
- Heller, R.
- de Groot, J.W.H.
- Stigt, JA
- Nuij, V.J.A.A. (Veerle)
- Pitz, C.C.M.
- Slingerland, M. (Marije)
- Borm, F.J.
- Haberkorn, B.C.M.
- Westeinde, S.C.V.
- Aarts, M.J.B. (Maureen)
- van Putten, J.W.G.
- Youssef, M.
- Cirkel, G.A. (Geert)
- Herder, G.J.
- van Rooijen, C.R.
- Citgez, E.
- Barlo, N.P.
- Scholtes, B.M.J.
- Koornstra, R.H.
- Claessens, N.J.M.
- Faber, LM
- Rikers, C.H.
- van de Wetering, R.A.W.
- Veurink, G.L.
- Bouter, B.W.
- Houtenbos, I.
- Bard, M.P.L.
- Herbschleb, K.H. (Karin)
- Kastelijn, E.A.
- Brocken, P.
- Douma, G.
- Jalving, M.
- Hiltermann, T.J.N.
- Schuurbiers-Siebers, O.C.J.
- Suijkerbuijk, K.P.M. (Karin)
- van Lindert, A.S.R.
- de Wouw, A.J.V.
- van den Boogaart, V.E.M.
- Bakker, S.D.
- Looysen, E.
- Peerdeman, A.L.
- de Jong, W.K.
- Siemerink, E.J.M.
- Staal, A.J.
- Franken, B.
- van Geffen, W.H.
- Bootsma, G.P. (G.)
DOIAbstract
Abstract Aim of the study: Patients with cancer might have an increased risk for severe outcome of coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse outcome of COVID-19, a nationwide registry was developed for patients with cancer and COVID-19. Methods: This observational cohort study has been designed as a quality of care registry and is executed by the Dutch Oncology COVID-19 Consortium (DOCC), a nationwide collaboration of oncology physicians in the Netherlands. A questionnaire has been developed to collect pseudonymised patient data on patients’ characteristics, cancer diagnosis and treatment. All patients with COVID-19 and a cancer diagnosis or treatment in the past 5 years are eligible. Resu...
Add to ORKG